Características clínicas y epidemiológicas de los pacientes con diagnóstico de tuberculosis multidrogorresistente en El Hospital Quillabamba 2012-2016.

Abstract

El presente trabajo de investigación intitulado CARACTERÍSTICAS CLÍNICAS Y EPIDEMIOLÓGICAS DE LOS PACIENTES CON DIAGNÓSTICO DE TUBERCULOSIS MULTIDROGORRESISTENTE EN EL HOSPITAL QUILLABAMBA 2012-2016 Cuyo objetivo fue determinar las características clínicas y epidemiológicas de los pacientes con diagnóstico de tuberculosis multidrogorresistente atendidos en el Hospital Quillabamba en los años 2012 a 2016; siendo un estudio descriptivo, transversal, retrospectivo. La muestra estuvo constituida por 36 Historias Clínicas completas de pacientes.

Llegando a los siguientes resultados 48.2% tuvo entre 30 a 59 años, 66.7% fueron del sexo masculino, 42.4% convivientes, 51.4% con instrucción Primaria, 94.4% tuvo trabajo independiente, 55.6% procede de la zona urbana, 55.5% comparten entre 3 a 4 personas una habitación, 72.2% nunca fue antes tratado por la tuberculosis, 55.6% tuvo contacto con otros pacientes con diagnóstico de tuberculosis multidrogorresistente, 75% presento tos más de 15 días, 50% presento tos con expectoración hemoptoica, 77.7% presento sudoración nocturna, 61.2% no presento fiebre, 66.5% no presento bajo peso, 41.8% tuvo aparentemente buen estado general, 69.4% no presento anemia, 50.1% tuvo apetito normal, 47.2% presento otras comorbilidades, 83.4% el medio de diagnóstico fue bacteriológico y radiológico, 61.2% su estado nutricional fue normal, 69.4% recibió el esquema de tratamiento empírico, 63.8% presento drogo resistencia a Isoniacida y Rifampicina, 75% su condición de alta fue curado.

This research paper titled CLINICAL AND EPIDEMIOLOGICAL OF PATIENTS WITH TUBERCULOSIS MULTIDRUG RESISTAND IN QUILLABAMBA HOSPITAL 2012-2016 The objective was to determine the clinical and epidemiological characteristics of patients diagnosed with multidrug-resistant tuberculosis treated at the Hospital in Quillabamba from 2012 to 2016; being a descriptive, transversal, retrospective study. The clinical trial consisted of 36 patients with complete medical history. The following results were met , 48.2% were between 30 and 59 years old, 66.7% were male, 42.4% were cohabitants, 51.4% had primary education, 94.4% had independent work, 55.6% came from urban areas, 55.5% shared between 3 to 4 people in a room, 72.2% were never treated before for tuberculosis, 55.6% had contact with other patients with multidrugresistant tuberculosis, 75% had a cough, 50% presented with expectoration

hemoptica,

77.7% were presented with night sweats, 61.2% had fevers, 66.5% did not present low weight, 41.8% had apparently a good general condition, 69.4% did not have anemia, 50.1% had normal appetite, 47.2% presented other comorbidities, in 83.4 % the means of diagnosis was bacteriological, 61.2% its nutritional status was normal, 69.4% received the empirical treatment scheme, 63.8% presented drug resistance to Isonic and Rifampicin, 75% their condition of discharge was cured.